Literature DB >> 14320529

A REVIEW OF DRUG THERAPY IN PARKINSONISM.

R C DUVOISIN.   

Abstract

Keywords:  DRUG THERAPY; PARKINSONISM

Mesh:

Year:  1965        PMID: 14320529      PMCID: PMC1750750     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN: 0028-7091


× No keyword cloud information.
  7 in total

1.  SELF-INDUCED STRAMONIUM INTOXICATION.

Authors:  E S DEAN
Journal:  JAMA       Date:  1963-09-14       Impact factor: 56.272

2.  Dynamic measurement of rigidity, strength, and tremor in Parkinson patients before and after destruction of mesial globus pallidus.

Authors:  D D WEBSTER
Journal:  Neurology       Date:  1960-02       Impact factor: 9.910

3.  Atropine coma: a somatic therapy in psychiatry.

Authors:  G R FORRER; J J MILLER
Journal:  Am J Psychiatry       Date:  1958-11       Impact factor: 18.112

4.  Quantitative measurement of therapy in paralysis agitans.

Authors:  F J AGATE; L J DOSHAY; F K CURTIS
Journal:  J Am Med Assoc       Date:  1956-02-04

5.  Mental symptoms in parkinsonism following benzhexol hydrochloride therapy.

Authors:  H B PORTEOUS; D N ROSS
Journal:  Br Med J       Date:  1956-07-21

6.  Antagonism of the effects of tremorine by tropine derivatives.

Authors:  M E FARQUHARSON; R G JOHNSTON
Journal:  Br J Pharmacol Chemother       Date:  1959-12

7.  [Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system].

Authors:  H EHRINGER; O HORNYKIEWICZ
Journal:  Klin Wochenschr       Date:  1960-12-15
  7 in total
  5 in total

Review 1.  Antiparkinsonian drugs: pharmacological and therapeutic aspects.

Authors:  D B Calne; J L Reid
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

3.  What Is the Most Important and Impactful Paper Related to Movement Disorder Therapy Published in the 20th Century?

Authors:  Stanley Fahn
Journal:  Mov Disord Clin Pract       Date:  2021-09-21

4.  Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors:  J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

5.  The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954.

Authors:  D M Coward; N S Doggett
Journal:  Psychopharmacology (Berl)       Date:  1977-04-29       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.